| Remus Pharmaceuticals Ltd | Industry : Pharmaceuticals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.02 | 0.07 | 0.32 | 0.05 | 0.12 |
| Long Term Debt-Equity Ratio | 0.02 | 0.06 | 0.28 | 0.03 | 0.09 |
| Current Ratio | 1.71 | 1.76 | 1.11 | 0.91 | 1.16 |
| Fixed Assets | 8.97 | 12.02 | 20.99 | 32.74 | 26.89 |
| Inventory | 39.48 | 58.66 | 47.90 | 18.04 | 23.17 |
| Debtors | 5.24 | 6.57 | 11.59 | 7.58 | 7.04 |
| Interest Cover Ratio | 71.11 | 66.74 | 50.61 | 52.22 | 48.00 |
| PBIDTM (%) | 36.50 | 37.24 | 26.92 | 19.66 | 8.74 |
| PBITM (%) | 34.13 | 35.49 | 25.85 | 19.05 | 7.76 |
| PBDTM (%) | 36.02 | 36.71 | 26.40 | 19.30 | 8.58 |
| CPM (%) | 27.50 | 27.74 | 19.94 | 14.48 | 6.73 |
| APATM (%) | 25.14 | 25.99 | 18.88 | 13.88 | 5.75 |
| ROCE (%) | 13.33 | 24.46 | 68.21 | 92.25 | 48.98 |
| RONW (%) | 10.06 | 19.25 | 66.10 | 70.58 | 41.09 |